NICE’s decision not to approve Zytiga ‘frustrating’, says ICR

16th July 2021 Uncategorised 0

Zytiga is used for the treatment of newly diagnosed, advanced prostate cancer patients

More: NICE’s decision not to approve Zytiga ‘frustrating’, says ICR
Source: News